https://n.neurology.org/content/early/2020/01/13/WNL.0000000000008944
Potential for treatment benefit of small molecule CGRP receptor antagonist plus monoclonal antibody in migraine therapy
Kathleen Mullin, David Kudrow, Robert Croop, Meghan Lovegren, Charles M. Conway, Vladimir Coric, Richard B. Lipton
First published January 13, 2020, DOI: https://doi.org/10.1212/WNL.0000000000008944
